English
Home > Products > 4-cyclopropylnaphthalen-1

China 4-cyclopropylnaphthalen-1 Factory

Our development depends on the advanced equipment, excellent talents and continuously strengthened technology forces for 4-cyclopropylnaphthalen-1,CAS NO 1533519-92-4,1533519-92-4,Lesinurad intermediate,Lesinurad advance intermediate, Presently, we are looking forward to even larger cooperation with overseas clients based on mutual benefits. Make sure you come to feel no cost to make contact with us for more information.
4-cyclopropylnaphthalen-1, With more than 9 years of experience and a skilled team, now we have exported our items to many countries and regions all over the world. We welcome customers, business associations and friends from all parts of the world to contact us and seek cooperation for mutual benefits.

Related Products

Hot Products

  • 2-amino-5-bromopyridin-3-ol

    2-amino-5-bromopyridin-3-ol

    Product Name:2-amino-5-bromopyridin-3-ol
    Molecular Formula:C5H5BrN2O
    Molecular Weight:189.01
    CAS Registry Number:39903-01-0
  • Methoprene

    Methoprene

    Product Name:Methoprene
    Molecular Formula:C19H34O3
    Molecular Weight;310.47
    CAS Registry Number;40596-69-8
  • MYOSMINE

    MYOSMINE

    Product Name:MYOSMINE
    Molecular Formula:C9H10N2
    Molecular Weight:146.19
    CAS Registry Number:532-12-7
  • Calcium levofolinate

    Calcium levofolinate

    Product Name:Calcium levofolinate
    Molecular Formula:C20H25CaN7O7
    Molecular Weight;515.54
    CAS Registry Number;80433-71-2
  • 2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester

    2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester

    Product Name:2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester
    Molecular Formula:C23H19N3O4
    Molecular Weight:401.41
    CAS Registry Number:136285-67-1
  • Capmatinib hydrochloride

    Capmatinib hydrochloride

    Product Name:Capmatinib hydrochloride
    Molecular Formula:C23H20ClFN6O2
    Molecular Weight;466.9
    CAS Registry Number;1865733-40-9
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

4-(4-cyclopropylnaphthalen-1-yl)Methyl 2-((4-(4-cyclopropylnaphthalen-1-yl)Methyl 2-(5-broMo-4-(4-cyclopropylnaphthalen-1-yl)

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept